StemBioSys Inc. has crossed another critical threshold in its evolution. The San Antonio-based biotech company has secured patent approval for three pending applications, including one in China and two in Australia.
Newsroom
StemBioSys Inc. has crossed another critical threshold in its evolution. The San Antonio-based biotech company has secured patent approval for three pending applications, including one in China and two in Australia.